ProPhase Labs Inc.

ProPhase Labs Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.23
Market Cap
$23.35 M
Shares Outstanding
11.56 M
Public Float
8.47 M

Profile

Address
621 North Shady Retreat Road
Doylestown Pennsylvania 18901
United States
Employees -
Website http://www.prophaselabs.com
Updated 07/08/2019
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products, dietary supplements, and other remedies. Its products include TK supplement and Organix Rx. The company was founded by Guy J.

Financials

View All
Created with Highcharts 5.0.14ProPhase Labs Inc.Net Income. Fiscal year is January-December. All values USD Thousands.4054057 8347 8343 6003 6004 0064 0062 2422 2421 5701 57020132014201520162017201802k4k6k8k10k
Created with Highcharts 5.0.14ProPhase Labs Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.25 03225 03222 07022 07020 60420 6044 2064 2069 8679 86713 12613 12620132014201520162017201805k10k15k20k25k30k

Ted William Karkus
Chairman & Chief Executive Officer
Jason Michael Barr
Independent Director